THE YEAR IN BRIEF

AddLife 2024

In 2024, the companies within AddLife focused on further strengthening their support for customers and patients while continuously developing their product portfolio to meet current and future needs.

Many of the companies' customers have faced staff shortages while the demand for healthcare, diagnostics, and research continues to grow. In this situation, the need for new technologies that can help improve efficiency and achieve more with existing personnel becomes increasingly essential. Additionally, reliable local service, support, and training are required to ensure expected results for customers. The companies within AddLife have consistently and credibly provided these solutions, strengthening customer relationships and growing faster than the market.

^{* Adjusted for contingent considerations and restructuring costs}

This strong growth demonstrates that our companies are well-positioned to expand market niches, that the customer offering is constantly evolving, and that customer relationships remain strong. In line with AddLife’s business model, the companies continuously work with cost control and efficiency improvements, which have resulted in enhanced profitability and cash flow.

The UK, Irish, and Spanish markets are where AddLife established a presence in 2021 and 2022. The acquired companies in these markets have performed exceptionally well, making the UK, Ireland, and Spain among AddLife’s most important markets today.

A continuous effort to efficiently utilize capital and resources is a key part of AddLife's business model. Driving improvements in cash flow to reduce debt and enable an increased acquisition pace is a high priority. Cash flow has strengthened in 2024, allowing AddLife to reduce debt by approximately half a billion SEK. The leverage, measured as Net Debt/EBITDA, has clearly decreased during the year toward the previously communicated target of 3.0 or below. This development enables a gradual increase in acquisition activities, a process that began in Q3 2024 with the acquisition of BonsaiLab.